Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs.
Open Access
- 28 October 1998
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 280 (16) , 1421-1426
- https://doi.org/10.1001/jama.280.16.1421
Abstract
POLICIES for the confidential reporting by name of persons with acquired immunodeficiency syndrome (AIDS) to health departments exist in all states.1 The ability to monitor trends in the epidemic due to the human immunodeficiency virus (HIV) has been based on these AIDS case reports. In contrast, confidential reporting by name of HIV-infected adults and adolescents (aged ≥13 years) who do not meet the criteria for AIDS (HIV reporting)1 has been implemented less completely; by January 1998, only 28 states required physicians and other health care providers, including clinicians, laboratories, and institutions (eg, hospitals, clinics), to report these cases.2 Until recently, AIDS case reporting met most of the information needs of monitoring and characterizing the HIV epidemic. Because of changes in the epidemic, most notably those related to new therapies, AIDS case reports no longer provide adequate information, and HIV reporting will become increasingly important.3,4Keywords
This publication has 7 references indexed in Scilit:
- National HIV Case Reporting for the United States — A Defining Moment in the History of the EpidemicNew England Journal of Medicine, 1997
- The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learnedAIDS, 1996
- HIV test-seeking before and after the restriction of anonymous testing in North Carolina.American Journal of Public Health, 1996
- Anonymous HIV testing: the impact of availability on demand in Arizona.American Journal of Public Health, 1994
- Many people who seek anonymous HIV-antibody testing would avoid it under other circumstancesAIDS, 1990
- Mandatory Reporting of HIV Testing Would Deter Men From Being TestedPublished by American Medical Association (AMA) ,1989
- TRIAL OF ANONYMOUS VERSUS CONFIDENTIAL HUMAN IMMUNODEFICIENCY VIRUS TESTINGThe Lancet, 1988